UW WELL-FIT Exercise Program for Cancer Patients (WELL-FIT)

March 25, 2025 updated by: Julia Fraser, University of Waterloo
The purpose of this project is to help to manage the many cancer treatment side effects through cardiovascular and resistance exercise, and education with the goal of using program outcomes to contribute to current research.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a single group pre-test post-test design.There are 4 optional measures that will be presented to participants from which they can choose to participate or not. These are presented with check boxes in the consent form. After completion of the University of Waterloo (UW) WELL-FIT program, participants will be given an option to continue with an exercise program; they will be offered the Graduate Program. Following consent of Graduate Program, repeated measures would be taken annually. At the time of consent, they will have the option to have their data used in research. At any point in their involvement of the exercise based programs, they can indicate "they no longer want to participate in the program or the data collection". Their medical care or participation in the UW WELL-FIT program will not be affected.

Procedures

  1. UW WELL-FIT advertisement for Grand River Regional Cancer Centre
  2. UW WELL-FIT brochure
  3. Referral Form
  4. Participants initial consultation and assessment
  5. Obtain consent for UW WELL-FIT
  6. Obtain Participant Information
  7. Completion of FACIT-F survey
  8. Metabolism & Body Composition - Information sheet for optional measures
  9. Physical Activity Survey- Godin Questionnaire
  10. Provide 3-Day food diary and Nutritional Assessment
  11. Fitness assessment, exercise programming and data entry:

    1. Submaximal cardiovascular cycle ergometer or treadmill graded exercise test
    2. Muscular strength using force transducer
    3. Body composition:

      • Height, weight and waist girth
      • Bioelectrical Impedance Analysis (BIA)
      • Dual Energy X-ray Absorption (Optional)
    4. Range of motion using a goniometer
    5. Blood sampling (Optional)
    6. Design Individualized exercise program
  12. UW WELL-FIT - Commencement of participant in 12 week exercise program (2 x 60 minute classes)
  13. Post assessment (repeated pre-test assessments)
  14. Pre and post data are entered into database
  15. Summary and Feedback Report
  16. Graduate Program: participant selects to attend UW WELL-FIT Graduate Program
  17. Participants have annual reassessments in the Graduate Program

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • previously diagnosed with cancer and will currently be receiving some form of treatment (chemotherapy, radiation therapy or hormonal therapy)

Exclusion Criteria:

  • Physical / health factors that prohibit exercise or lack of medical clearance from physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiovascular and strength training exercise
24 sessions (~12 weeks) exercise
Cardiovascular and resistance exercise training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Exercise Test
Time Frame: 24 sessions (12 weeks)
Pre and post maximum workload using an electronic cycle ergometer in Watts
24 sessions (12 weeks)
Upper and Lower Limb Strength
Time Frame: 24 sessions (12 weeks)
pre and post strength in upper and lower limb muscles using a linear differential variable transducer (LVDT) measured in Newton.meters
24 sessions (12 weeks)
Body Mass Index
Time Frame: 24 sessions (12 weeks)
Pre and post body mass index (kg/m2)
24 sessions (12 weeks)
Percent Body Fat
Time Frame: 24 sessions (12 weeks)
Pre and Post percent body fat (units: %)
24 sessions (12 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose
Time Frame: 24 sessions (12 weeks)
measurement of blood glucose in mM
24 sessions (12 weeks)
Lipids
Time Frame: 24 sessions (12 weeks)
measurement of total cholesterol, low density lipoprotein,high density lipoprotein ( millimole per liter (mM/L)
24 sessions (12 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marina Mourtzakis, PhD, University of Waterloo
  • Principal Investigator: Caryl Russell, MSc, University of Waterloo
  • Principal Investigator: Michael Sharratt, PhD, University of Waterloo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

February 9, 2016

First Submitted That Met QC Criteria

April 11, 2016

First Posted (Estimated)

April 12, 2016

Study Record Updates

Last Update Posted (Actual)

March 30, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ORE18987-A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Exercise

Subscribe